本页面由Tiger Trade Technology Pte. Ltd.提供服务

Viking Therapeutics, Inc.

28.73
+0.22000.77%
成交量:95.27万
成交额:2,698.50万
市值:36.20亿
市盈率:-6.16
高:28.83
开:28.17
低:27.91
收:28.51
52周最高:43.15
52周最低:25.77
股本:1.26亿
流通股本:1.23亿
量比:0.50
换手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-4.6676
每股收益(LYR):-3.1920
净资产收益率:-88.85%
总资产收益率:-51.86%
市净率:8.87
市盈率(LYR):-9.00

数据加载中...

2026/09/28

重要事件披露

Form 8-K - Current report
2026/09/24

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/09/22

重要事件披露

Form 8-K - Current report
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/26

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/02/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities